Trademark Overview
On Wednesday, June 24, 2026, a trademark application was filed for INTERCEPT with the United States Patent and Trademark Office. The USPTO has given the INTERCEPT trademark a serial number of 99902818. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 24, 2026. This trademark is owned by Stripe, LLC. The INTERCEPT trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:
Accepting and administering monetary charitable contributions on behalf of organizations engaged in the research, development, production, and distribution of vaccines and broad-spectrum prophylactic treatments for respiratory diseases, and organizations developing non-pharmaceutical interventions for respiratory disease prevention; Investment of funds for others in the fields of vaccine and broad-spectrum prophylactic research, development, production, and distribution, and non-pharmaceutical interventions for respiratory disease prevention; Financial investment in the field of vaccine and broad-spectrum prophylactic research, development, production, and distribution, and non-pharmaceutical interventions for respiratory disease prevention; Financial management in the field of investment in vaccine and broad-spectrum prophylactic research, development, production, and distribution, and non-pharmaceutical interventions for respiratory disease prevention; Charitable fundraising to suppo...
Business consultation services to assist non-profit organizations in planning, managing, and conducting fundraising activities; Promoting the interests of organizations engaged in the research, development, production, and distribution of vaccines and broad-spectrum prophylactic treatments for respiratory diseases, and organizations developing non-pharmaceutical interventions for respiratory disease prevention by means of public advocacy; Promoting public awareness of the need for research, development, production, and distribution of vaccines and broad-spectrum prophylactic treatments for respiratory diseases, and the benefits of non-pharmaceutical interventions for respiratory disease prevention by means of public advocacy; Providing public policy information in the field of vaccine and broad-spectrum prophylactic research, development, production, and distribution, and non-pharmaceutical interventions for respiratory disease prevention; Public policy consultancy in the field of vacc...
